- Sensory Processing Disorders are Associated with Duration of Current Episode and Severity of Side Effects
-
Serafini G, Engel-Yeger B, Vazquez GH, Pompili M, Amore M
- KMID: 2365012
- Psychiatry Investig.
- 2017 Jan;14(1):51-57.
- doi: 10.4306/pi.2017.14.1.51
OBJECTIVE: Longer duration of untreated illness, longer duration of current episode, and the severity of medication side effects may negatively impact on the perceived disability and psychosocial impairment of patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Alexithymia, Suicide Ideation and Homocysteine Levels in Drug Naïve Patients with Major Depression: A Study in the “Real World†Clinical Practice
-
De Berardis D, Olivieri L, Rapini G, Di Natale , Serroni N, Fornaro M, Orsolini L, Valchera A, Carano A, Vellante F, Varasano P, Pressanti , Serafini G, Pompili M, Martinotti G, Di Giannantonio M
- KMID: 2456736
- Clin Psychopharmacol Neurosci.
- 2019 Mar;17(2):318-322.
- doi: 10.9758/cpn.2019.17.2.318
OBJECTIVE: This study was performed to elucidate relationships between alexithymia, suicide ideation and homocysteine levels in drug-naïve outpatients with major depressive disorder (MDD). METHODS: Sixty seven outpatients with MDD with melancholic... -
- CITED
-
- Close
- SHARE
-
- Close
- Understanding the Complex of Suicide in Depression: from Research to Clinics
-
Orsolini L, Latini R, Pompili M, Serafini G, Volpe U, Vellante F, Fornaro M, Valchera A, Tomasetti , Fraticelli S, Alessandrini M, La Rovere , Trotta S, Martinotti G, Di Giannantonio M, De Berardis D
- KMID: 2501498
- Psychiatry Investig.
- 2020 Mar;17(3):207-221.
- doi: 10.30773/pi.2019.0171
Objective Amongst psychiatric disorders, major depressive disorder (MDD) is the most prevalent, by affecting approximately 15–17% of the population and showing a high suicide risk rate equivalent to around 15%.... -
- CITED
-
- Close
- SHARE
-
- Close
- High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients
-
Pellicelli A, Messina V, Giannelli , Distefano , Palitti VP, Vignally P, Tarquini P, Izzi A, Moretti A, Babudieri , Dell’Isola S, Marignani , Scifo G, Iovinella , Cariti G, Pompili M, Candilo FD, Fontanella L, Ettorre GM, Vennarecci G, Ippolito A, Barbarini
- KMID: 2500540
- Gut Liver.
- 2020 May;14(3):357-367.
- doi: 10.5009/gnl18269
Background/Aims: Patients with genotype 3 hepatitis C virus (G3-HCV) cirrhosis are very difficult to treat compared to patients with other HCV genotypes. The optimal treatment duration and drug regimen associated... -
- CITED
-
- Close
- SHARE
-
- Close
